You are here

Drugmakers seek incentives to develop antibiotics to fight 'superbugs'

They also call for diagnostic tests so that antibacterial drugs are not used needlessly
Friday, January 22, 2016 - 05:50
pharm.jpg
More than 80 pharmaceutical and diagnostic companies from around the world are calling for new economic models to spur development of badly needed new antibiotics and to fight the rising global threat of drug-resistant "superbugs."

New York

MORE than 80 pharmaceutical and diagnostic companies from around the world are calling for new economic models to spur development of badly needed new antibiotics and to fight the rising global threat of drug-resistant "superbugs."

In a declaration that is being released

Powered by GET.comGetCom